Global Embolotherapy Market 2021
- Piyasa Raporu
- İD: HL22896G
- Teslimat süresi: 1 İş günü
- Etiket: Embolotherapy
Tanım
Embolotherapy is a type of endovascular treatment that aims to occlude abnormal blood vessels in order to control bleeding, close fistulae or arteriovenous malformations, devascularise organs, reduce tumours and much more. To accomplish occlusion, embolotherapy uses minimally-invasive techniques and various embolic agents, such as gelfoam, coils, balloons and angiographic catheters to achieve precise and significant results. The global embolotherapy market is set to grow by US$ 1.50 sırasında milyar 2021-2027, yıllık bileşik büyüme oranında büyüyor (CAGR) ile ilgili 6.6% tahmin dönemi boyunca, veri ve analiz şirketi StratejiHelix'e göre. Growing target population, expanding applications of embolotherapy devices, escalating prevalence of chronic and lifestyle-associated diseases, increasing healthcare expenditure, and improving healthcare infrastructure are expected to boost the market growth in the coming years.
Rapor, döneme ilişkin güncel pazar büyüklüğü verilerini sağlar 2017-2020 ve tahmin 2027 covering key market aspects like sales value for embolotherapy. The global embolotherapy market is segmented on the basis of product, indication, procedure, region, and end user. Ürüne göre, it is categorized into embolic agents, and support devices. The embolic agents segment held the largest market share in 2020. By indication, the embolotherapy market is divided into cancer, neurological diseases, peripheral vascular diseases, urological and nephrological disorders, and gastrointestinal disorders. The cancer segment accounted for the largest market share in 2020. Based on procedure, the embolotherapy market is divided into transcatheter arterial embolization, transarterial chemoembolization, and transarterial radioembolization/selective internal radiation therapy. Embolotherapy market by region is divided into North America, Asya Pasifik, Avrupa, and Rest of the World (ROW).
The report has profiled some of the key players of the market such as Acandis GmbH, Balt Extrusion SAS, Boston Scientific Corporation, Cook Group Incorporated, Guerbet SA, Johnson & Johnson, Kaneka Corporation, Medtronic plc, Meril Life Sciences Private Limited, Merit Medical Systems Inc., Penumbra Inc., Sirtex Medical Limited, Stryker Corporation, Terumo Corporation.
Rapor, bu sektörde faaliyet gösteren şirket ve kuruluşlar için paha biçilmez bir kaynaktır. It provides a cohesive picture of the embolotherapy market to help drive informed decision making for industry executives, kural koyucular, akademik, ve analistler.
Rapor Kapsamı
Ürün: embolic agents, and support devices
Indication: cancer, neurological diseases, peripheral vascular diseases, urological and nephrological disorders, and gastrointestinal disorders
Procedure: transcatheter arterial embolization, transarterial chemoembolization, and transarterial radioembolization/selective internal radiation therapy
End user: hospitals and clinics, ambulatory surgical centers (ascs), ve diğerleri
Bölge: Kuzey Amerika, Asya Pasifik, Avrupa, and Rest of the World (ROW)
Düşünülen Yıllar: bu rapor dönemi kapsamaktadır 2017 ile 2027
Paydaşlar için Temel Faydalar
Get a comprehensive picture of the global embolotherapy market
Identify regional strategies and strategic priorities on the basis of local data and analysis
Büyüme sektörlerini ve yatırım eğilimlerini belirleyin
Understand what the future of the global embolotherapy market looks like
Rekabet ortamını ve fırsat penceresini belirleyin
İçindekiler
1. Pazar Tanımı
2. Araştırma Metodolojisi
3. Piyasa verileri & Görünüm
3.1 Market değeri
3.2 Piyasa Değeri Tahmini
4. Embolotherapy Market by Product
4.1 Embolic Agents
4.2 Support Devices
5. Embolotherapy Market by Indication
5.1 Cancer
5.2 Neurological Diseases
5.3 Peripheral Vascular Diseases
5.4 Urological And Nephrological Disorders
5.5 Gastrointestinal Disorders
6. Embolotherapy Market by Procedure
6.1 Transcatheter Arterial Embolization
6.2 Transarterial Chemoembolization
6.3 Transarterial Radioembolization/Selective Internal Radiation Therapy
7. Embolotherapy Market by Region
7.1 Kuzey Amerika
7.2 Asya Pasifik
7.3 Avrupa
7.4 Rest Of The World (Row)
8. Embolotherapy Market by End User
8.1 Hospitals And Clinics
8.2 Ayaktan Cerrahi Merkezleri (Ascs)
8.3 Diğerleri
9. Şirket profilleri
9.1 Acandis GmbH
9.2 Balt Extrusion SAS
9.3 Boston Scientific Corporation
9.4 Cook Group Incorporated
9.5 Guerbet SA
9.6 Johnson & Johnson
9.7 Kaneka Corporation
9.8 Medtronic plc
9.9 Meril Life Sciences Private Limited
9.10 Merit Medical Systems Inc.
9.11 Penumbra, A.Ş..
9.12 Sirtex Medical Limited
9.13 Stryker Corporation
9.14 Terumo Corporation
10. Ek
10.1 StratejiHelix Hakkında
10.2 Sorumluluk reddi beyanı
Amerikan Doları 2,750